Ivan Lieberburg

Active 1975–2012

54
Papers
32,368
Citations
53
h-index
54
i10-index

Citations

Citations per year for Ivan Lieberburg1975: 2 citations1977: 4 citations1978: 8 citations1979: 23 citations1980: 11 citations1981: 25 citations1982: 10 citations1983: 12 citations1984: 10 citations1985: 10 citations1986: 4 citations1987: 11 citations1988: 31 citations1989: 61 citations1990: 89 citations1991: 120 citations1992: 196 citations1993: 299 citations1994: 413 citations1995: 346 citations1996: 421 citations1997: 455 citations1998: 419 citations1999: 460 citations2000: 623 citations2001: 647 citations2002: 698 citations2003: 606 citations2004: 536 citations2005: 457 citations2006: 465 citations2007: 419 citations2008: 453 citations2009: 396 citations2010: 454 citations2011: 413 citations2012: 426 citations2013: 291 citations2014: 306 citations2015: 232 citations2016: 251 citations2017: 209 citations2018: 170 citations2019: 389 citations2020: 367 citations2021: 331 citations2022: 295 citations2023: 204 citations2024: 303 citations2025: 147 citations2026: 5 citations1976: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,781 citing papers, 39.5% of this breakdownGermany: 859 citing papers, 7.1% of this breakdownUnited Kingdom: 761 citing papers, 6.3% of this breakdownJapan: 626 citing papers, 5.2% of this breakdownChina: 457 citing papers, 3.8% of this breakdownCanada: 441 citing papers, 3.6% of this breakdownSweden: 387 citing papers, 3.2% of this breakdownItaly: 371 citing papers, 3.1% of this breakdownAustralia: 358 citing papers, 3% of this breakdownFrance: 312 citing papers, 2.6% of this breakdownSwitzerland: 294 citing papers, 2.4% of this breakdownBelgium: 259 citing papers, 2.1% of this breakdown
0%39.5%Other 18.1%

Fields

  • Medicine75%
  • Biochemistry, Genetics and Molecular Biology12.2%
  • Neuroscience7.9%
  • Computer Science1.4%
  • Psychology0.7%
  • Agricultural and Biological Sciences0.5%
  • Other2.3%

Topics

  • Alzheimer's disease research and treatments25%
  • Cholinesterase and Neurodegenerative Diseases6.7%
  • Computational Drug Discovery Methods6.6%
  • Neuroinflammation and Neurodegeneration Mechanisms3.9%
  • Prion Diseases and Protein Misfolding3.6%
  • Dementia and Cognitive Impairment Research3.5%
  • Other50.7%

Coauthors

All papers

Open in search
  1. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature 1999 cited by 3,158

  2. Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis

    Authors: , , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2012 cited by 510

  3. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James Vitale, Sam Wadsworth, Ben Wolozin, Jun Zhao - Nature 1995 cited by 2,509

  4. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2000 cited by 2,006

  5. A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease

    Authors: , , , , , , , , , , , , , , , , , - Neurology 2009 cited by 739

  6. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production

    Authors: , , , , , , , , - Nature 1992 cited by 1,753

  7. Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease

    Authors: , , , , , , , , , , , , , , , , - Annals of Neurology 1995 cited by 694

  8. Amyloid β-peptide is produced by cultured cells during normal metabolism

    Authors: , , , , , , , , , , - Nature 1992 cited by 1,907

  9. beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity

    Authors: , , , , , - Journal of Neuroscience 1992 cited by 1,628

  10. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids

    Authors: , , , , , , , , , , , , , , - Nature 1992 cited by 1,740

  11. Purification and cloning of amyloid precursor protein β-secretase from human brain

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 1999 cited by 1,598

  12. Mutation of the Alzheimer's Disease Amyloid Gene in Hereditary Cerebral Hemorrhage, Dutch Type

    Authors: , , , , , , , , - Science 1990 cited by 1,389

  13. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 1997 cited by 1,267

  14. Estrogen Therapy in Postmenopausal Women

    Authors: , , , - JAMA 1998 cited by 939

  15. Functional gamma‐secretase inhibitors reduce beta‐amyloid peptide levels in brain

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chen Yin, Dale B. Schenk, Patrick C. May, L. Altstiel, Mark H. Bender, Leonard N. Boggs, T. C. Britton, James C. Clemens, Dan L. Czilli, Donna K. Dieckman-McGinty, J. J. Droste, Kimberly S. Fuson, Bruce D. Gitter, Paul A. Hyslop, Edward M. Johnstone, W‐Y. Li, Sharon Little, Thomas E. Mabry, F. DeWolfe Miller, B. Ni, Jeffrey S. Nissen, Warren J. Porter, B D Potts, Jon K. Reel, Diane Stephenson, Yuan Su, Lisa A. Shipley, Celia A. Whitesitt, Tao Yin, James E. Audia - Journal of Neurochemistry 2001 cited by 879

  16. Amyloid precursor protein processing and Aβ 42 deposition in a transgenic mouse model of Alzheimer disease

    Authors: , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1997 cited by 658

  17. Lethality of Alzheimer Disease and Its Impact on Nursing Home Placement

    Authors: , , , - Alzheimer Disease & Associated Disorders 2010 cited by 121

  18. High Cerebrospinal Fluid Tau and Low Amyloid β42 Levels in the Clinical Diagnosis of Alzheimer Disease and Relation to Apolipoprotein E Genotype

    Authors: , , , , , , , , , , , , , , , - Archives of Neurology 1998 cited by 446

  19. Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide

    Authors: , , , , , , , , , , , - Nature 1993 cited by 547

  20. Cellular mechanisms of β-amyloid production and secretion

    Authors: , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1999 cited by 436

  21. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein

    Authors: , , , , , - Neuron 1993 cited by 799

  22. β-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease

    Authors: , , , , , - Trends in Neurosciences 1993 cited by 520

  23. Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease

    Authors: , , , , , , , , , , - Neurology 1995 cited by 226

  24. Production and increased detection of amyloid β protein and amyloidogenic fragments in brain microvessels, meningeal vessels and choroid plexus in Alzheimer's disease

    Authors: , , , , - Molecular Brain Research 1996 cited by 120